Floatz logo

Capecitabine

Endometrial

Western Regional Medical CenterSmall moleculePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Endometrial cohort.

Asset / SponsorPhaseRating
Levonorgestrel
Washington University School of Medicine
Phase 2CCC
Zanidatamab
UNICANCER
Phase 2CCC
Semaglutide
Washington University School of Medicine
Phase 2CCC
Temsirolimus
Western Regional Medical Center
Phase 1/2CCC
Pasifolate Exatecan
Elucida Oncology
Phase 1/2CCC

View all 12 →

Same molecule, other indications

Capecitabine is also rated in:

Locally Advanced Rectal CancerDormant
BBB
Indicative ·
75 / 100
View asset →
colorectal neoplasmDormant
BBB
Indicative ·
74 / 100
View asset →
rectal carcinomaDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →